[Remote] Medical Science Liaison / Sr. Medical Science Liaison at Azurity Pharmaceuticals

Remote

Azurity Pharmaceuticals Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a doctoral-level qualification (PharmD, PhD, MD) and have at least 5 years of experience in the pharmaceutical or biotech industry. A strong background in cardiovascular medicine, hypertension management, or related fields is preferred. The role requires up to 60% travel within the US.

Responsibilities

The Medical Science Liaison will build and maintain relationships with Key Opinion Leaders (KOLs) and healthcare providers (HCPs) through scientific exchanges. They will deliver medical education and presentations on products and disease states to various stakeholders, including internal teams, cardiologists, managed care organizations, and payers. This role involves acting as the primary contact for medical and scientific inquiries, gathering competitive intelligence at medical meetings, and supporting company-sponsored trials and investigator-initiated research. Additionally, the MSL will assist with medical communications, grant proposals, health economics research, speaker training, Advisory Boards, and sales training, while staying current on cardiovascular disease states and competitive landscapes. The position emphasizes a focus on hypertension within the cardiovascular therapeutic area.

Skills

Cardiovascular
Medical Affairs
KOL Engagement
HCP Engagement
Scientific Exchange
Product Development
Stakeholder Engagement

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters
2000Year Founded
$182.2MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
401(k) Retirement Plan
Paid Vacation
Paid Holidays
Hybrid Work Options
Professional Development Budget
Tuition Reimbursement
Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.
Integration challenges from Slayback Pharma acquisition may disrupt operations.
Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.
Their FDA-approved products ensure safety and efficacy in specialized formulations.
Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.
Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.
FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI